About
Bio
Circulation:
The publisher does not disclose the circulation
Frequency:
Bi-Monthly
Aims of the journal:
Lung Cancer Management aims to address key issues and current understanding in the diagnosis, staging and treatment of the disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal seeks to provide oncologists and other health professionals with the latest findings and opinions on reducing the burden of lung cancer. Recent research findings and advances in clinical practice in the field are reported and analysed by international experts, and the importance of the most recent advances in molecular biology are explained.
Readership:
Oncologists and other health professionals.
Content:
Coverage includes:
Biological therapies
Biomarkers
Clinical trials
Comparative effectiveness
Diagnosis and imaging
Molecular biology of disease
Molecular diagnostics
Pharmacoeconomics
Radiotherapy
Risk and prevention
Surgical approaches
Systemic therapies
Editorial contacts:
The Editorial Board can be seen here.
Manuscript Submission:
Unsolicited manuscripts are accepted for publication; contact the Commissioning Editor with a brief proposal and article outline. All review articles published in the journals are subject to rigorous peer-review by independent experts in the field.
Author guidelines can be viewed at here.
Online submission can be found here.
Ad Rates:
Further information on ad rates can be found here.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Oncology
Bio
Circulation: The publisher does not disclose the circulation Frequency: Bi-Monthly Aims of the journal: Lung Cancer Management aims to address key issues and current understanding in the diagnosis, staging and treatment of the disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal seeks to provide oncologists and other health professionals with the latest findings and opinions on reducing the burden of lung cancer. Recent research findings and advances in clinical practice in the field are reported and analysed by international experts, and the importance of the most recent advances in molecular biology are explained. Readership: Oncologists and other health professionals. Content: Coverage includes: Biological therapies Biomarkers Clinical trials Comparative effectiveness Diagnosis and imaging Molecular biology of disease Molecular diagnostics Pharmacoeconomics Radiotherapy Risk and prevention Surgical approaches Systemic therapies Editorial contacts: The Editorial Board can be seen here. Manuscript Submission: Unsolicited manuscripts are accepted for publication; contact the Commissioning Editor with a brief proposal and article outline. All review articles published in the journals are subject to rigorous peer-review by independent experts in the field. Author guidelines can be viewed at here. Online submission can be found here. Ad Rates: Further information on ad rates can be found here.
Website
Social media
Location
Frequency
Circulation
Sectors
Oncology
Most recent articles by Lung Cancer Management
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to Lung Cancer Management
-
OncologyLiveEstablished in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com
ViewMMedical News TodayBackground and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
View
Targeted OncologyTargeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.
ViewJJAMA OncologySet to launch in February 2015, this medical journal aimed at physicians covers oncology. Will feature all aspects of medical, radiation, and surgical oncology and its subspecialties
ViewAASH Clinical NewsASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.
ViewUse CisionOne to find more relevant outletsContact Lung Cancer Management and get access to over 850K accurate, up-to-date media profiles.
Discover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.
